Related Experiment Video
Updated: Sep 12, 2025
14:43
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
12.0K
Pregnancy outcomes and vitiligo: protocol for a scoping review
Behnaz Esmaeili1, Mahin Afroushe1, Shahnaz Esmaeili2
1Department of Basic Medical Sciences, Khoy University of Medical Sciences, Khoy, Iran.
BMJ Open
|August 7, 2025
Summary
This review examines pregnancy outcomes in women with vitiligo, a skin condition. It synthesizes current research to clarify risks and inform clinical practice regarding vitiligo and pregnancy.
Area of Science:
- Dermatology
- Obstetrics
- Autoimmune Diseases
Background:
- Autoimmune diseases impact pregnancy, posing risks to mothers and fetuses.
- Vitiligo, a depigmentation disorder, has controversial associations with adverse pregnancy outcomes (APOs).
Purpose of the Study:
- To conduct a scoping review of existing literature on pregnancy outcomes in patients with vitiligo.
- To explore and summarize the current evidence regarding adverse pregnancy outcomes (APOs) in vitiligo patients.
Main Methods:
- A five-stage scoping review methodology (Arksey and O'Malley) will be employed.
- Literature searches will be conducted in PubMed and Scopus databases up to January 2025.
- Data extraction and charting will be performed by two reviewers, with results presented using tables and graphs.
Main Results:
- This section is to be populated upon study completion.
- The review will map the available evidence on pregnancy outcomes in vitiligo patients.
- Analysis will focus on identifying and exploring reported adverse pregnancy outcomes (APOs).
Conclusions:
- This scoping review will provide a comprehensive overview of pregnancy outcomes in vitiligo patients.
- Findings will help clarify the relationship between vitiligo and adverse pregnancy outcomes (APOs).
- Results will be disseminated through peer-reviewed publications.
Related Concept Videos
01:14Changes in Skin Color: Clinical Perspectives
2.2K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.2K
01:07Teratogenicity
2.8K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174